HSBC Holdings’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,302
Closed -$68.5K 3123
2025
Q3
$68.5K Buy
+16,302
New +$104K ﹤0.01% 2624
2025
Q2
Sell
-13,987
Closed -$136K 3208
2025
Q1
$136K Sell
13,987
-21
-0.1% -$260 ﹤0.01% 2729
2024
Q4
$175K Buy
+14,008
New +$170K ﹤0.01% 2759
2024
Q3
Sell
-29,344
Closed -$253K 3126
2024
Q2
$253K Buy
29,344
+17,072
+139% +$119K ﹤0.01% 2406
2024
Q1
$100K Sell
12,272
-11,260
-48% -$92.3K ﹤0.01% 2846
2023
Q4
$195K Buy
23,532
+3,814
+19% +$44.2K ﹤0.01% 2479
2023
Q3
$325K Buy
19,718
+6,144
+45% +$121K ﹤0.01% 2180
2023
Q2
$321K Buy
+13,574
New +$265K ﹤0.01% 2123

Other funds holding REPL

HSBC Holdings's REPL Position: Q4 2025 in Review

HSBC Holdings sold out of Replimune Group (REPL) in Q4 2025, closing a stake of 16,302 shares — an estimated $68.5K sold.

HSBC Holdings first reported a position in REPL in Q2 2023 and held it in 8 quarters. The position peaked at $325K in Q3 2023. 164 funds tracked by Wall St. Rank hold REPL as of Q4 2025.

  • HSBC Holdings reported no remaining Replimune Group position as of Q4 2025 after selling out during the quarter.
  • HSBC Holdings sold 16,302 Replimune Group shares in Q4 2025, an estimated $68.5K.
  • HSBC Holdings first reported a position in Replimune Group in Q2 2023 and held it in 8 quarters.
  • HSBC Holdings's Replimune Group position peaked at $325K in Q3 2023.
  • 164 funds tracked by Wall St. Rank held Replimune Group as of Q4 2025.

Based on HSBC Holdings's 13F filing for Q4 2025, filed 6 Mar 2026.